Moderna raises $451.4M, per SEC filing

mRNA therapeutics company Moderna Therapeutics Inc. (Cambridge, Mass.) has raised $451.4 million towards a planned $600 million venture round, according to an SEC filing from last week.

The new financing would bring Moderna's equity haul to more than $1 billion. According to BioCentury's BCIQ database, Moderna has raised $740 million in venture capital since its inception, including $140 million earlier this month from AstraZeneca plc (LSE:AZN; NYSE:AZN) (see BioCentury Extra, Aug. 10). ...